Samuel showcased AI's latest innovations at the Development Center for Biotechnology
On August 24, our CEO Samuel was invited to speak at an event titled “Multiplied Efficiency: Introduction and Practice of AI Avatar in the Biomedical Industry – Successful cases Studies in the CRO Sector” to highlight the latest innovations in AI application, specifically AI avatars in the field of biotechnology.
The event was held by the Development Center for Biotechnology (DCB), a government-funded institution dedicated to bolstering research, development, and the commercialization of technological breakthroughs in the medical and pharmaceutical sectors.
Being a first in Taiwan, Samuel’s AI avatar effectively eliminates the language barrier in communication, which is often one of the biggest hurdles impacting international collaborations with foreign entities. With real-time, seamless AI translation available in English, Japanese, German, and several other languages, this groundbreaking platform significantly reduces delays and accelerates innovations in drugs and medical devices.
Alongside Samuel’s success story, Jerry Chen, General Manager of S&G Corporation, presented a blueprint of creating an AI avatar customized to unique scenarios.
Bestat would like to express gratitude to the DCB for the opportunity and looks forward to future expansion of AI technology in the local and global biomedical industry.
Read more：
1. https://finance.ettoday.net/news/2568500
2. https://www.moneyweekly.com.tw/ArticleData/Info/Article/127903
On August 24, our CEO Samuel was invited to speak at an event titled “Multiplied Efficiency: Introduction and Practice of AI Avatar in the Biomedical Industry – Successful cases Studies in the CRO Sector” to highlight the latest innovations in AI application, specifically AI avatars in the field of biotechnology.
The event was held by the Development Center for Biotechnology (DCB), a government-funded institution dedicated to bolstering research, development, and the commercialization of technological breakthroughs in the medical and pharmaceutical sectors.
Being a first in Taiwan, Samuel’s AI avatar effectively eliminates the language barrier in communication, which is often one of the biggest hurdles impacting international collaborations with foreign entities. With real-time, seamless AI translation available in English, Japanese, German, and several other languages, this groundbreaking platform significantly reduces delays and accelerates innovations in drugs and medical devices.
Alongside Samuel’s success story, Jerry Chen, General Manager of S&G Corporation, presented a blueprint of creating an AI avatar customized to unique scenarios.
Bestat would like to express gratitude to the DCB for the opportunity and looks forward to future expansion of AI technology in the local and global biomedical industry.
Read more：
1. https://finance.ettoday.net/news/2568500
2. https://www.moneyweekly.com.tw/ArticleData/Info/Article/127903